Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia, Myeloid, Acute 11Myelodysplastic Syndromes 9Lymphoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Hematologic Neoplasms 6Neuroblastoma 4Neoplasms 4Melanoma 4Lymphoma, Non-Hodgkin 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Lymphoid 3Hodgkin Disease 3Hematologic Diseases 3Sarcoma 2Rhabdoid Tumor 2Recurrence 2Preleukemia 2Precancerous Conditions 2Osteosarcoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Histologic Type 2Multiple Myeloma 2Lymphoproliferative Disorders 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid 2

Interventions

Etoposide 7Cisplatin 7fludarabine 4Cyclophosphamide 4fludarabine phosphate 3Paclitaxel 3Carboplatin 3Bleomycin 3Automobiles 3pembrolizumab 2etoposide phosphate 2Vorinostat 2Sirolimus 2Mesna 2Ifosfamide 2Drug Therapy 2130-nm albumin-bound paclitaxel 2tremelimumab 1tozuleristide 1sodium thiosulfate 1repotrectinib 1pralsetinib 1pegfilgrastim 1lutetium Lu 177 dotatate 1durvalumab 1cabozantinib 1Watchful Waiting 1Teniposide 1Surveys and Questionnaires 1Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Mesna × 1 year × Clear all
NCT04897321 2026-05-19

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

St. Jude Children's Research Hospital

Phase 1 Recruiting
48 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Adrenal Cortex Neoplasms, Carcinoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Neurofibrosarcoma, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

NCT01873326 2025-07-03

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
92 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡